CARSON MICHAEL J. (Vice President, Finance) sold 3.0% of their position (2.75K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market sale worth $22.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/8/2024ACC: 0001104659-24-115837
Officer· Vice President, Finance
Since Mar 2022
+60.62K
Net shares
Net buyer
$22.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
63.37K acquired · 2.75K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+28.81K
Price / share
—
Trade value
—
% of position
105.5%
1/3/2023
27.30K→56.11K
Common Stock
Direct
Shares
+34.57K
Price / share
—
Trade value
—
% of position
61.6%
1/4/2024
56.11K→90.67K
Common Stock
Direct
Shares
−2.75K
Price / share
$8.16
Trade value
$22.48K
% of position
3.0%
11/7/2024
90.67K→87.92K
Total
Net shares
+60.62K
Net value
-$22.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2023 | A · Award | +28.81K | — | — | 105.5% | 27.30K | 56.11K |
| Common Stock Direct | 1/4/2024 | A · Award | +34.57K | — | — | 61.6% | 56.11K | 90.67K |
| Common Stock Direct | 11/7/2024 | S · Sale | −2.75K | $8.16 | $22.48K | 3.0% | 90.67K | 87.92K |
| Total | +60.62K | -$22.48K | ||||||
Derivative Transactions0
No derivative transactions reported